J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Apocard

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 12 USDMF, 14 CEP/COS, 1 JDMF, 7 EU WC, 1 KDMF, 9 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

127 FDF Dossiers, 31 FDA Orange Book, 66 Europe, 12 Canada, 8 Australia, 6 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 DKSH, 3 Faran Shimi Pharmaceutical, 5 Gangwal Healthcare, 1 Shanghai Minbiotech, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 4 Kerry, 9 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 18 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 20 Lubricants & Glidants, 17 Disintegrants & Superdisintegrants, 14 Direct Compression, 13 Co-Processed Excipients, 11 Thickeners and Stabilizers, 9 Granulation, 7 Coating Systems & Additives, 6 Chewable & Orodispersible Aids, 5 Film Formers & Plasticizers, 5 Taste Masking, 4 Controlled & Modified Release, 3 Emulsifying Agents, 2 Rheology Modifiers, 1 API Stability Enhancers, 1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 53 Regulatory FDF Prices

MARKET PLACE

15 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/06/2025	Unimark Remedies	India	UNIMARK REMEDIES LIMITED Mumbai IN	R1-CEP 2009-289 - Rev 01	Flecainide acetate, Process A	2015-03-19	Suspended by Holder	Chemical	2024-05-07	1324
28/06/2025	Unimark Remedies	India	UNIMARK REMEDIES LIMITED Mumbai IN	R1-CEP 2006-005 - Rev 02	Flecainide acetate	2020-08-13	Suspended by Holder	Chemical	2024-05-07	1324

Apocard

Apocard

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers

12 USDMF

14 CEP/COS

1 JDMF

7 EU WC

1 KDMF

9 NDC API

16 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

127 FDF Dossiers

31 FDA Orange Book

66 Europe

12 Canada

8 Australia

6 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

5 SPI Pharma

2 DKSH

3 Faran Shimi Pharmaceutical

5 Gangwal Healthcare

1 Shanghai Minbiotech

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 BASF

3 DFE Pharma

4 Gangwal Chemicals

1 Ideal Cures

3 Ingredion Pharma Solutions

4 Kerry

9 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

18 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders

20 Lubricants & Glidants

17 Disintegrants & Superdisintegrants

14 Direct Compression

13 Co-Processed Excipients

11 Thickeners and Stabilizers

9 Granulation

7 Coating Systems & Additives

6 Chewable & Orodispersible Aids

5 Film Formers & Plasticizers

5 Taste Masking

4 Controlled & Modified Release

3 Emulsifying Agents

2 Rheology Modifiers

1 API Stability Enhancers

1 Topical

DIGITAL CONTENT

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

53 Regulatory FDF Prices

MARKET PLACE

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons